BREAKING: The FDA has accepted for review the new drug application (NDA) for Kowa Pharmaceuticals America’s K-911 (bimatoprost grenod; also known as NCX 470).
Read more: hubs.li/Q04vzTDT0
Carolyn Majcher, OD, FAAO, discussed her prediction for how physicians will implement changes in nAMD treatment following FDA approval of bevacizumab-vikg (Lytenava).
For the full video, visit hubs.li/Q04vcsp-0
👁️ In this week's roundup from Optometry Times, key clinical trial and FDA developments take the spotlight.
For the latest in eye care research and expert advice on patient care, check out our recap: hubs.li/Q04tVsCz0
Mile Brujic, OD, FAAO, reframes pediatric “compliance” by noting that children’s lives are already structured around rules and schedules set by adults.
Learn the latest in pediatric patient care on our website: hubs.li/Q04rqywP0
In an exclusive interview with Optometry Times, Katie W. Chu, OD, discussed her approach to LASIK conversations with parents of pediatric patients.
For more information, view the full video at hubs.li/Q04txCT70
